“Panel Discussion: Treatment Options for Relapsed Refractory Diffuse Large B-Cell Lymphoma (R R DLBCL) Patients”. 2022. Canadian Hematology Today 1 (S10). https://doi.org/10.58931/cht.2022.1S1029.